Search

everythinglearnresearchcommunity

for

Search:↓

Using 5-alpha reductase inhibitors may lower prostate cancer risk in people with androgenetic alopecia.

Wedelolactone selectively kills prostate cancer cells without harming normal cells.

New pyrazole-based inhibitors show promise for treating metabolic diseases and other conditions.

A man developed oral hairy leukoplakia while on baricitinib, a medication for alopecia and arthritis, and doctors should watch for such side effects.

Baricitinib significantly regrows hair in teens with severe alopecia areata.

Germacrone from Curcuma aeruginosa may help treat conditions related to male hormones by blocking a specific enzyme.

Skin side effects from CDK4/6 inhibitors in breast cancer patients are generally mild and treatable, allowing most patients to continue treatment.

The document concludes that various topical treatments show promise for skin conditions like atopic dermatitis, psoriasis, and hair loss.

Prostaglandin E2 helps prevent hair loss from radiotherapy by protecting hair growth cells and aiding self-repair.

Guselkumab effectively reduces fatigue in Psoriatic Arthritis patients over two years.

Inhibiting retinoic acid activates WNT signaling, potentially aiding hair disorder and skin cancer treatments.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

Baricitinib helps long-term hair regrowth in severe alopecia areata patients.

Upadacitinib may effectively treat twenty-nail dystrophy without causing pain.

PI3Kδ inhibition may effectively treat cutaneous chronic graft-versus-host disease.

9-cis-retinoic acid showed some effectiveness in treating AIDS-related Kaposi sarcoma but had significant side effects at higher doses.

CP-690,550 significantly reduced itching in patients with moderate-to-severe plaque psoriasis.

Andrographolide-loaded topical nanocarriers are a safe and effective treatment for psoriasis.

GLP-1 receptor agonists can cause skin and hair issues due to rapid weight loss, but these can be managed with proper care and treatments.

JAK inhibitors help hair regrowth but not fully effective for androgenetic alopecia.

The S1PR 1&4 modulator may effectively treat alopecia areata by reducing hair loss and immune cell activity.

Intramuscular cyproterone acetate effectively treats hirsutism and improves skin conditions in women with hyperandrogenism.

Tideglusib helps heal wounds in older skin.

Higher alarin levels might link hair loss and metabolic syndrome.

Clascoterone is a new, effective, and safe acne treatment without systemic side effects.

Baricitinib effectively improves symptoms of atopic dermatitis and alopecia areata with few side effects.

Scientists found a new gene in a bacterium that can modify an immunosuppressant drug, potentially helping to treat hair loss.

Araliadiol may promote hair growth like minoxidil without being toxic.

A new treatment using nanoliposomes can improve hair regrowth in androgenetic alopecia.

Ritlecitinib effectively treats alopecia areata and is safe for long-term use in people 12 and older.